Home|Journals|Articles by Year|Audio Abstracts

Regular Article

Pharmacological, phytochemical and morphological study of three Mayan accessions of Bixa orellana L. leaves

Addy Leticia Zarza-García, Enrique Sauri-Duch, Denise Raddatz-Mota, Luis Cuevas-Glory, Luis Pinzón-López, Fernando Rivera-Cabrera, Jose Alberto Mendoza-Espinoza.


Achiote (Bixa orellana L.) is a plant native to tropical America. The seeds of this plant are often used in the food industry, but the leaves are underutilized. In the southeastern region of Mexico, the annatto leaves are used in the traditional Mayan medicine. While the dosage and the quality remain unclear, and we studied the chemical profile and biological activity of annatto leaves from three accessions. The qualitative analysis showed low presence of saponins and abundant anthraquinones. The annatto leaf extracts of accessions 2 and 3 had a higher content of total phenolic compounds and antioxidant capacity compared to accession 1. Accession 3 showed anti-inflammatory effects similar to indomethacin. In conclusion, the annatto leaves of accession 3 could be used to prepare phytomedicines due to its anti-inflammatory capacity. These results add medicinal and economic value to this crop, and indicate the importance of performing detailed pharmacological studies.

Key words: achiote, anti-inflammatory activity, antioxidant capacity, phytochemical analysis, total phenolic compounds.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.